1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Evolocumab |
| brand | String | Repatha |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:PCSK9_inhibitors|PCSK9 inhibitor]] • [[:Category:Lipid-lowering_agents|Lipid-lowering agent]] • [[:Category:Biologics|Biologic]] • [[:Category:Monoclonal_antibodies|Monoclonal antibody (fully human IgG2)]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-0000147C-QINU`"', '"`UNIQ--vote-0000147D-QINU`"', '"`UNIQ--vote-0000147E-QINU`"' |
| starting_dose | String | 140 mg SC every 2 weeks OR 420 mg SC monthly (3 consecutive injections 5 minutes apart due to volume) |
| preparations | String | 140 mg/mL single-use prefilled syringe and SureClick autoinjector; Pushtronex 420 mg/3.5 mL on-body infusor |
| fda_max | String | 420 mg/month |
| pill_id | Text | |
| routes | List of String, delimiter: , | Subcutaneous |
| onset | String | LDL reduction ~50-60% from baseline at 1-2 weeks |
| duration | String | 2-4 weeks per dose |
| halflife | String | ~11-17 days'"`UNIQ--ref-0000147F-QINU`"' |
| bioavailability | String | ~72% from SC depot'"`UNIQ--ref-00001480-QINU`"' |
| pregnancy | String | Limited data.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
